Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production

PloS One
Ariana Barbera BetancourtMaja Wallberg

Abstract

Type 1 diabetes is caused by the destruction of insulin producing beta cells by the immune system. The p110δ isoform of PI3K is expressed primarily in cells of haematopoietic origin and the catalytic activity of p110δ is important for the activation of these cells. Targeting of this pathway offers an opportunity to reduce immune cell activity without unwanted side effects. We have explored the effects of a specific p110δ isoform inhibitor, IC87114, on diabetogenic T cells both in vitro and in vivo, and find that although pharmacological inhibition of p110δ has a considerable impact on the production of pro-inflammatory cytokines, it does not delay the onset of diabetes after adoptive transfer of diabetogenic cells. Further, we demonstrate that combination treatment with CTLA4-Ig does not improve the efficacy of treatment, but instead attenuates the protective effects seen with CTLA4-Ig treatment alone. Our results suggest that decreased IL-10 production by Foxp3+ CD4+ T cells in the presence of IC87114 negates individual anti-inflammatory effects of IC8114 and CTLA4-Ig.

References

Apr 2, 2003·Nature Reviews. Immunology·Klaus Okkenhaug, Bart Vanhaesebroeck
Feb 3, 2004·The Journal of Clinical Investigation·Sefina ArifMark Peakman
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tim RaineAnne Cooke
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel T PattonKlaus Okkenhaug
Apr 17, 2008·European Journal of Immunology·Tara M RandisThomas G Diacovo
Jan 9, 2009·Clinical and Experimental Immunology·A WillcoxN G Morgan
Feb 4, 2009·The Journal of Clinical Investigation·David BendingAnne Cooke
May 12, 2009·Nature Genetics·Jeffrey C BarrettUNKNOWN Type 1 Diabetes Genetics Consortium
Jan 6, 2011·Clinical Chemistry·Andrea K Steck, Marian J Rewers
Jan 11, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maja WållbergE Allison Green
Apr 5, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ningwen TaiLi Wen
Aug 23, 2012·Diabetes·Thomas DelongKathryn Haskins
Jan 22, 2013·Annual Review of Immunology·Klaus Okkenhaug
Sep 24, 2013·Trends in Immunology·Maja Wållberg, Anne Cooke
Dec 17, 2014·Biochimica Et Biophysica Acta·P T Hawkins, L R Stephens

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
ELISA
PMA

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.